Cryptocurrency treasury company Trend Research has dumped a substantial portion of its Ether holdings as the asset nears the company’s liquidation threshold belowCryptocurrency treasury company Trend Research has dumped a substantial portion of its Ether holdings as the asset nears the company’s liquidation threshold below

Best Crypto to Buy Now: DeepSnitch AI Jumps 153% Amid 100x Forecast as Canton and Stable Sell-Off in Crash, Trend Research Liquidates ETH Holding

2026/02/10 14:56
5 min read

Cryptocurrency treasury company Trend Research has dumped a substantial portion of its Ether holdings as the asset nears the company’s liquidation threshold below $1,700.

This move comes as DeepSnitch AI rallies by 153% amid speculation it could soar 100x. Emerging from the AI sector, DeepSnitch AI is set to capture a significant share of this market. 

As a result, over $1.50 million has been invested in its presale at $0.03906 in stage five. Given its presale performance, some speculate it might be the best crypto to buy now.

Trend Research liquidates 400k ETH 

Treasury company Trend Research was forced to sell part of its ETH holdings as the asset continued to dip to pay off a substantial loan.

As of February 1, Trend Research had about 651,170 ETH in Aave Ethereum Wrapped Ether (AETHWETH) in its reserve. This figure was depleted by 404,090 on February 6, leaving around 247,080. 

According to Arkham Intelligence, the company has moved 411,075 ETH to Binance since the start of February. This transfer coincided with Ether’s price crashing by 30% over the week. Due to this decline, ETH now trades at $2,040.

3 top cryptocurrencies to buy today for solid returns this year

1. DeepSnitch AI pushes 100x narrative amid bearish market

Despite the bearish state of the crypto market, DeepSnitch AI has not failed to shine. While other assets plummeted, DeepSnitch AI’s token DSNT rose in value, defying the overall market outlook. 

DeepSnitch AI is a platform that issues AI agents that retailers can use to frontrun trades and spot market opportunities early. 

These AI agents, built into a dashboard, track whale movements, on-chain activity, shifts in market sentiment, and signals retailers can follow in making investment decisions. In short, they help investors make profitable trading decisions. 

The reason DeepSnitch AI is one of the trending coins this week is that, while the rest of the market dipped, DSNT rose 153% to $0.03906. This upswing was followed by $1.5 million in investment during its presale.

As a result of this performance, many believe it could be the next crypto to 100x this cycle. Should this forecast materialize, DeepSnitch AI could be the best crypto to buy now. 

2. Stable price prediction: Price dips after mainnet upgrade

Stable network released a new update on February 4 to strengthen its production readiness, with improvements to token usability, developer ergonomics, and chain observability. 

Implementing this upgrade enabled the network to switch from the wrapped gUSDT token to USDT0 as its gas token. Fixation of solidity codes and staking improvements, and undelegation tracking were additional features of the upgrade.

However, the Stable token crashed, as did the broader crypto market, this week. STABLE fell 29.34% over the week to $0.016. With no signs of a reversal yet, Stable could dive even lower. 

3. Canton price prediction: Fireblocks brings regulated settlement to the network 

Fireblocks has partnered with the Canton Network to enable the secure, regulated application of the Canton Coin for financial institutions. 

This integration used Fireblocks’ NYDFs-regulated trust entity and super validator node, bolstering support for institutional clients.

This development comes as the price of Canton Coin drops amid sellers dominating the crypto market. CC dipped 4% over the week to $0.17.

As one of the trending coins this week, investors anticipate a recovery once the market rebounds.

The bottom line

While Canton Coin and Stable fell under bearish influence, DeepSnitch AI stood firm in the grasp of the bulls. The price of its native token went up 153% to $0.03906 instead.

Many have dubbed DeepSnitch AI the best crypto to buy now, given this price action. The coin also currently looks primed for an additional upswing, which could make it the next crypto to 100x.

A bonus framework was introduced for the DeepSnitch AI presale, under which up to 300% of the tokens an investor buys above $30,000 will be sent to their wallets. Without this, they can earn more by holding or participating in the platform’s uncapped staking program.

Visit the official website for more information, and join Telegram for community updates.

FAQs

1. Why is DeepSnitch AI the best crypto to buy now?

Despite the recent market onslaught, DeepSnitch AI jumped 153%, leaving early investors in its presale in profit while others incurred losses from the dip.

DeepSnitch AI, Canton Coin, and Stable are the top coins in the headlines today, but for different reasons. While Canton and Stable were spotlighted among the underperformers despite making strides the previous week, DeepSnitch AI rallied by 152%. 

3. Will DeepSnitch AI be the next crypto to 100x?

It is likely DeepSnitch AI will be the next crypto to 100x, given that the adoption rate of its native token keeps increasing and interest in its AI agents continues rising. Savvy investors have now invested $1.40 million in DeepSnitch AI at $0.03906 to board the 100x train.

DISCLAIMER: CAPTAINALTCOIN DOES NOT ENDORSE INVESTING IN ANY PROJECT MENTIONED IN SPONSORED ARTICLES. EXERCISE CAUTION AND DO THOROUGH RESEARCH BEFORE INVESTING YOUR MONEY. CaptainAltcoin takes no responsibility for its accuracy or quality. This content was not written by CaptainAltcoin’s team. We strongly advise readers to do their own thorough research before interacting with any featured companies. The information provided is not financial or legal advice. Neither CaptainAltcoin nor any third party recommends buying or selling any financial products. Investing in crypto assets is high-risk; consider the potential for loss. Any investment decisions made based on this content are at the sole risk of the readCaptainAltcoin is not liable for any damages or losses from using or relying on this content.

The post Best Crypto to Buy Now: DeepSnitch AI Jumps 153% Amid 100x Forecast as Canton and Stable Sell-Off in Crash, Trend Research Liquidates ETH Holding appeared first on CaptainAltcoin.

Market Opportunity
Nowchain Logo
Nowchain Price(NOW)
$0.0012761
$0.0012761$0.0012761
+24.72%
USD
Nowchain (NOW) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của CEO Bitget Gracy Chen Trở Thành Hiện Thực Và Tầm Nhìn Về Đích Đến 5.400 USD

Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của CEO Bitget Gracy Chen Trở Thành Hiện Thực Và Tầm Nhìn Về Đích Đến 5.400 USD

Thị trường tài chính toàn cầu vừa chứng kiến một khoảnh khắc lịch sử chấn động: Giá Vàng thế giới [...] The post Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của
Share
Vneconomics2026/02/10 16:26
Why the Bitcoin Boom Is Not Another Tulip Mania

Why the Bitcoin Boom Is Not Another Tulip Mania

Bitcoin is an amazing success story. It was only invented in January of 2009 and was only worth a tiny fraction of a cent for each token. Over just a few years
Share
Medium2026/02/10 15:44
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26